OraSure Technologies Inc
Închisă
SectorSănătate
4.3 1.9
Rezumat
Modificarea prețului
24h
Minim
4.22
Maxim
4.32
Venit | -6.3M -22M |
|---|---|
Vânzări | 1.2M 28M |
EPS | -0.24 |
Marjă de profit | -80.132 |
Angajați | 500 |
EBITDA | -1.8M -21M |
Următoarele câștiguri | 4 aug. 2026 |
|---|
Capitalizare de piață | 36M 249M |
|---|---|
Deschiderea anterioară | 2.4 |
Închiderea anterioară | 4.3 |
Sentimentul știrilor
By Acuity
19%
81%
32 / 344 Clasament în Healthcare
OraSure Technologies Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
OraSure Technologies Inc Așteptări
Sentiment
By Acuity
32 / 344 Clasament în Sănătate
Sentimentul știrilor
Evidențe foarte puternice de creștere
Volatilitate
Sub medie
Volumul știrilor (RCV)
Sub medie
Date financiare
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
